Delivery Order SPE2DB24D1034-SPE2DB25FWFJ1
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide AJOVY 225 MG/1.5 ML syringes. The $1,556.88 contract has a completion date of March 15, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical that serves as the primary vehicle for the company to deliver pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL syringes, with a ceiling value of $1,092.00. This competitive, firm fixed-price delivery order was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AJOVY is a prescription medication used primarily for the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $6,017.34 to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL auto-injector units. This firm fixed-price delivery order, issued on September 29, 2025, represents a non-set-aside, competitively awarded contract with an ultimate completion date of September 30, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,820.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract, which carries no set-aside designation, represents a competitively awarded order with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a $1,092.00 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, a pharmaceutical product used in the treatment of chronic migraine. This competitively awarded, firm fixed-price contract was issued on May 12, 2025, with an ultimate completion date of May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this order...
- The Defense Logistics Agency awarded a $6,655.88 delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units, with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award Management. This delivery...
- This is a $1,045.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of AJOVY 225 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through April 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $1,943.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for AJOVY (fremanezumab) 225 mg/1.5 mL syringes on September 26, 2025, with completion targeted for September 29, 2025. This non-set-aside award represents a pediatric migraine prevention medication delivery to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $4,840.30 to AmerisourceBergen Drug Corp for the supply of AJOVY (fremanezumab) 225 mg/1.5 mL auto-injector units. This contract, issued on October 8, 2025, with an ultimate completion date of October 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's headquarters location. This...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFJ1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 ml syringes, valued at $1,092.00, with a completion date of August 28, 2025. This non-competitive, firm fixed-price delivery order was issued on August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen's role as a primary pharmaceutical distributor to the Defense Logistics Agency reflects its established position as a critical vendor for federal medical procurement, serving military and veteran healthcare systems with a diverse portfolio of medications, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/27/25 |